Research & Development in
Schlieren
52 companies in Research & Development based in Schlieren — name and year of registration from the commercial register.
50 of 52 companies
Molecular Partners AG
Since 2004 · 101–500 empl.4.9(11)
The company develops innovative therapeutic compounds, in particular DARPins, for diseases with high unmet medical need, with a focus on ophthalmology and oncology.
InSphero AG
Since 2009 · 51–100 empl.5.0(8)
The core activity of InSphero is the development and provision of 3D cell culture technologies and solutions for drug discovery and research. In particular, the company focuses on the development of 3D cell culture systems, such as the Akura system, which enables researchers to create so-called spheroids to test the effect of drugs on cells. InSphero's solutions are used in various fields, including liver safety research, liver disease research, islet biology, oncology, and immunology.
LimmaTech Biologics AG
Since 2015 · 51–100 empl.4.8(4)
The core activity of LimmaTech Biologics AG is the development and manufacture of vaccines and other biotechnological products, particularly in the field of infectious diseases. The company focuses on the development of a proprietary vaccine platform and has a pipeline of products in various stages of development.
Zippsafe AG
Since 2016 · 11–20 empl.5.0(6)
The core activity of Zippsafe is the development and provision of intelligent locker and management systems for staff changing rooms and the secure storage of patient property in hospitals and other facilities. The systems include physical lockers, intelligent bags and software for management and logging. The goal is to minimize the space required in changing rooms while simultaneously increasing comfort and security for users.
Kuros Biosciences AG
Since 1995 · 51–100 empl.4.0(7)
Kuros Biosciences AG develops, researches and commercializes biomaterial-based bone graft products under the MagnetOs brand. Products include MagnetOs Putty, Granules, Easypack Putty and Flex Matrix for spine, extremities, trauma and oncology applications. The MagnetOs range uses a submicron "NeedleGrip" surface to modulate the immune response and is supported by preclinical and clinical research, including Level I studies.
indie Technologies Switzerland AG
Since 2003 · 101–500 empl.5.0(4)
The company indie develops and manufactures advanced technologies for the automotive industry, particularly in the fields of photonics, radar sensors and systems. The core activities include the development of solutions for driver assistance systems, autonomous driving, interior and exterior lighting, power and charging technology, as well as user experience. The company focuses on developing high-performance, energy-efficient and cost-effective solutions for the automotive industry.
BIO-TECHNOPARK Schlieren-Zürich
Since 2009 · 1–10 empl.5.0(6)
The core activity of Bio-Technopark Schlieren-Zurich is to promote companies in the life sciences, particularly in the fields of biotechnology, medical technology, pharmacy and pharmacology. This includes services such as consulting, coaching and support in the founding and development of companies, as well as in the search for financing. The Bio-Technopark also offers infrastructure such as laboratories and office space for start-ups, spin-offs and established companies. In addition, it organizes events and networking meetings to promote professional exchange and further education in the industry.
Mabylon AG
Since 2011 · 11–20 empl.4.7(3)
The core activity of Mabylon AG is research and development in the field of biotechnology.
InterAx Biotech AG
Since 2016 · 11–20 empl.5.0(2)
The core activity of InterAx Biotech AG is the development of solutions in the field of computer-aided chemistry and systems biology, particularly in the context of GPCR signaling pathways and medicinal chemistry. The company combines expertise in computer science, biology, chemistry, and pharmacy to develop innovative approaches for the development of drugs and therapies.
GeoSIG AG
Since 1992 · 1–10 empl.
GeoSIG AG provides monitoring and measurement solutions for earthquakes, seismic activity and structural, dynamic and static applications. The company designs and manufactures seismometers, accelerometers, recorders/digitizers, data acquisition systems, alarms/switches and related software for uses such as earthquake early warning, structural health monitoring, dam and power‑plant surveillance and other infrastructure projects.
DUALSYSTEMS BIOTECH AG
Since 2000 · 1–10 empl.
The core activity of Dualsystems Biotech AG is the provision of services in the field of proteomics, particularly in the identification of protein-protein interactions in living cells, with a focus on the cell membrane. The company offers specialized platforms such as LRC-TriCEPS and HATRIC-LRC to identify the targets of extracellular ligands (such as small molecules, peptides, proteins, antibodies, ADCs, Fc-fusion proteins, and viruses).
PolyGEL Tec AG
Since 2002 · 1–10 empl.
PolyGEL Tec AG is a company whose website mainly references the related brands or entities Acsana AG, Innutri AG and swissGEL AG. The site itself provides very limited content and mainly shows these links together with the NovoGEL Holding AG reference.
Redbiotec AG
Since 2006 · 11–20 empl.
The core activity of Redbiotec AG is the development and production of key proteins and genetic materials for the biopharmaceutical and food industries. The company focuses on the research and development of therapeutic bacteria for the treatment of cancer and genetic diseases.
Microbe Investigations AG
Since 2012 · 21–50 empl.
The core activity of Microbe Investigations AG (MIS) is to provide services as a Contract Research Organization (CRO) and test laboratory, particularly in the field of antimicrobial efficacy testing of products against bacteria, viruses, fungi and insects. The company offers customized R&D solutions for customers from various industries, including the development and testing of disinfectants, cosmetics, plastics, textiles and paints.
Axanton Technology GmbH
Since 2013 · 1–10 empl.
Axanton Technology GmbH develops MEMS (Molecules Establishing Membrane Signaling), a technology for producing therapeutic biomolecules that target chemically modified membrane protein sequences to restore membrane protein homeostasis. The company conducts research and preclinical development of candidates such as A‑144 and holds patented technology for MEMS production.
PharmaBiome AG
Since 2015 · 11–20 empl.
The core activity of PharmaBiome is the research and development of therapies in the field of the microbiome, particularly in the analysis and production of microbial technologies. The company focuses on developing solutions that improve the function of the microbiome and offers analytical and production-related technologies to this end.
Repertoire Immune Medicines (Switzerland) AG
Since 2018 · 21–50 empl.
The core activity of Repertoire Immune Medicines is the development of innovative immunotherapies for various therapeutic areas, particularly for cancer, autoimmune diseases, and infectious diseases. The company utilizes its proprietary DECODE platform to decipher the unique immune codes of the human body and develop medicines that can program the immune system to selectively eliminate tumors or restore balance to the immune system in autoimmune diseases.
Athebio AG
Since 2019 · 21–50 empl.
The core activity of Athebio AG is the development and provision of proprietary technology for the creation of targeted therapeutics with improved efficacy and safety, particularly through the use of "plug & play" DARPin technology (Athebody). The company focuses on partnering with pharmaceutical companies to develop and market innovative medicines.
Acytronix GmbH
Since 2024 · 1–10 empl.5.0(14)
The core activity of Acytronix is the development and provision of solutions for the purification of bio-entities from biosamples, particularly the isolation of extracellular vesicles (EVs) and biological nanoparticles. The company offers customized separation services, lyophilized separated products, and devices for rapid EV separation.
Synergene Biotech GmbH
Since 2001 · 1–10 empl.
Synergene Biotech GmbH provides services for the life sciences community and develops custom projects. The website lists services including sequencing (overnight sequencing), barcode and postpay sample submission, primer lists, software tools, and support for sample preparation, laboratory techniques and data analysis.
Fabas Foods AG
Since 2021 · 11–20 empl.
The core activity of Fabas Foods AG is the development of raw material solutions and ingredient systems for milk alternatives, with the goal of creating a more sustainable food future.
BiognoSYS AG
Since 2008 · 51–100 empl.5.0(1)
The core activity of Biognosys is the development and provision of technologies and services in the field of proteomics, particularly in the areas of large-scale proteomics, biomarker discovery and analysis. The company offers software, kits and contract research services to support customers in life science research and drug development.
Microcaps AG
Since 2019 · 21–50 empl.4.0(5)
The core activity of Microcaps AG is the development and application of microfluidic technology for the encapsulation of substances, particularly for the Fine Fragrances, Cosmetics, Nutrition, Pharmaceuticals and Technology industries. The company offers solutions for the encapsulation of active ingredients and fragrances and has its own production.
Neurimmune Subone AG
Since 2007 · 1–10 empl.5.0(1)
Neurimmune Subone AG is a biopharmaceutical company that translates human immune memory into antibody therapeutics. It develops monoclonal antibody candidates for indications including Alzheimer’s disease, amyotrophic lateral sclerosis, spinal cord injury, ATTR cardiomyopathy and type‑2 diabetes, applying its Reverse Translational Medicine™ (RTM™) technology platform and pursuing discovery, early clinical development and strategic partnerships.
Polaroid Therapeutics AG
Since 2023 · 1–10 empl.
Polaroid Therapeutics AG develops proprietary technologies to reduce bioburden and support antimicrobial therapies. Its activities focus on wound management products, long‑lasting medical‑device coatings and therapeutic applications employing methods such as 3D printing, artificial intelligence and advanced delivery systems.
hemotune AG
Since 2017 · 21–50 empl.5.0(3)
The core activity of hemotune AG is the development and manufacture of blood purification technology, particularly for the treatment of critical illnesses such as sepsis. The company focuses on researching and developing innovative solutions for blood purification and collaborates with an interdisciplinary team of experts from materials science, engineering, and medicine to develop and disseminate this technology.
Veralit AG
Since 1984 · 1–10 empl.4.0(10)
The core activity of Veralit AG is the development and manufacture of technical surfaces and coatings for various industries. The company offers a range of coating processes, including chemical nickel plating, veralizing and others, to improve the properties of materials such as corrosion resistance, wear resistance and adhesion. The coatings are used for various applications such as tool and machine components, food industry and other sectors.
rqmicro AG
Since 2013 · 11–20 empl.3.0(2)
The core activity of rqmicro AG is the development and provision of solutions for microbiological monitoring and control in various water applications, particularly in evaporative cooling systems and cooling towers. The company offers laboratory services, instruments and technologies to monitor and improve water quality.
arcoris bio AG
Since 2024 · 11–20 empl.
The core activity of arcoris bio AG is the development and application of innovative technologies for multiplex and multimodal imaging of RNA and proteins, particularly with MUSE nanotechnology. This technology enables the simultaneous detection and imaging of multiple biomolecules without specialized equipment and is used in various applications such as RNA-FISH, immunofluorescence, FACS, and IHC. The company also offers customized solutions and services for research and diagnostics.
Neurimmune AG
Since 2017 · 11–20 empl.5.0(1)
Neurimmune AG is a biopharmaceutical company that translates human immune memory into therapeutic antibodies and develops drug candidates for central nervous system and protein-aggregation diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis, ATTR cardiomyopathy, spinal cord injury and type‑2 diabetes.
Proxima Bio GmbH
Since 2026 · 21–50 empl.
Proxima Bio GmbH develops AI-based platforms for drug discovery and the analysis of protein interactions. The company focuses on structure prediction, molecular design, and data platforms for proximity-modulation therapeutics.
CDDS AG
Since 2025 · 1–10 empl.
CDDS AG develops autonomous counter-drone systems for detecting, tracking, and neutralizing hostile unmanned aerial threats. Its offering includes the CDDS Aircraft, an AI-powered interceptor drone, and the CDDS System, a launch station for storing, charging, and deploying multiple interceptors.
DAiNA Laboratories AG
Since 2025 · 1–10 empl.
DAiNA Laboratories AG develops approaches for personalized cancer care. The company combines AI with molecular data and biological analyses to characterize tumors individually and support treatment decisions.
Arcnivaris Life Sciences GmbH
Since 2026 · 1–10 empl.
Arcnivaris Life Sciences GmbH is a consulting company for cosmetics and life sciences. It supports projects in product positioning, development paths, regulatory positioning, and market entry.
ALP Bio AG
Since 2026 · 1–10 empl.
ALP Bio AG develops a platform for immunogenicity analysis in biologics development. The company combines human tonsil organoid technology with AI-based protein analysis to assess and reduce anti-drug antibody risk in therapeutic antibodies earlier in development.
BK Energie Mess AG
Since 1992 · 1–10 empl.
The core activity of BK ENERGIE MESS AG is mobile measurement technology for energy and environmental measurements. The company offers a wide range of measurement services, including heat measurement, energy measurement, flow measurement, pressure measurement, humidity measurement, gas and steam measurement, power measurement, and climate measurement. Measurements are carried out using mobile measurement systems, which are also suitable for temporary measurements. The results are analyzed and presented in the form of reports and graphics. The company supports customers in optimizing their energy consumption and environmental conditions.
Vital View Diagnostics AG
Since 2025 · 1–10 empl.
Valobena AG
Since 1997 · 1–10 empl.
Maag Innovations GmbH
Since 2014 · 1–10 empl.
sourceIN GmbH
Since 2016 · 1–10 empl.
NexMR AG
Since 2022 · 1–10 empl.
TYPHON Engineering & Consulting GmbH
Since 2023 · 1–10 empl.
Vivtex GmbH
Since 2023 · 1–10 empl.
EVIS Bioscience AG
Since 2024 · 1–10 empl.
MindX Labs GmbH
Since 2024 · 1–10 empl.
BIRDS Technology Studio GmbH
Since 2024 · 1–10 empl.
SYDRA AG
Since 2024 · 1–10 empl.
Sony Europe Limited, Weybridge, Swiss Branch Schlieren
Since 2024 · 1–10 empl.
DVSense AG
Since 2024 · 1–10 empl.
Livality AG
Since 2025 · 1–10 empl.
Research & Development in Schlieren
Research & Development in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of October 10, 2026
Research & Development in other places
By canton